All companies › HRMY

HRMY · Harmony Biosciences Holdings, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells7
Research cases0
Last filing2026-09-18

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-04 — Budur Kumar · sold 5,500 @ $41.98 2026-09-08 — Budur Kumar · sold 1,000 @ $42.79 2026-09-08 — Budur Kumar · sold 22,954 @ $43.10 2026-09-08 — Budur Kumar · sold 4,500 @ $42.25 2026-09-16 — Budur Kumar · sold 1,800 @ $43.01 2026-09-17 — Budur Kumar · sold 800 @ $43.00 2026-09-18 — Budur Kumar · sold 35,852 @ $43.05
2026-09-042026-09-18

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Budur Kumar CHIEF MEDICAL OFFICER
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $HRMY is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-18', 'insider_name': 'Budur Kumar', 'insider_title': 'CHIEF MEDICAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 35852.0, 'price': 43.05, 'value': 1543428.6, 'is_buy': False}, {'transaction_date': '2026-09-17', 'insider_name': 'Budur Kumar', 'insider_title': 'CHIEF MEDICAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 800.0, 'price': 43.0, 'value': 34400.0, 'is_buy': False}, {'transaction_date': '2026-09-16', 'insider_name': 'Budur Kumar', 'insider_title': 'CHIEF MEDICAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 1800.0, 'price': 43.01, 'value': 77418.0, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Budur Kumar', 'insider_title': 'CHIEF MEDICAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 1000.0, 'price': 42.79, 'value': 42790.0, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Budur Kumar', 'insider_title': 'CHIEF MEDICAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 22954.0, 'price': 43.1, 'value': 989317.4, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Budur Kumar', 'insider_title': 'CHIEF MEDICAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 4500.0, 'price': 42.25, 'value': 190125.0, 'is_buy': False}, {'transaction_date': '2026-09-04', 'insider_name': 'Budur Kumar', 'insider_title': 'CHIEF MEDICAL OFFICER', 'transaction_type': 'Open-market sell', 'shares': 5500.0, 'price': 41.98, 'value': 230890.0, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for HRMY today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.